Aurora kinase A messenger RNA overexpression is correlated with tumor progression and shortened survival in head and neck squamous cell carcinoma
- PMID: 16951231
- DOI: 10.1158/1078-0432.CCR-05-1650
Aurora kinase A messenger RNA overexpression is correlated with tumor progression and shortened survival in head and neck squamous cell carcinoma
Abstract
Purpose: Aurora kinase A (AURKA/STK15/BTAK) encodes a serine/threonine kinase associated with chromosomal distribution and its up-regulation induces chromosomal instability, thereby leading to aneuploidy and cell transformation in several types of cancer. In this study, we investigated the role of AURKA in head and neck squamous cell carcinoma (HNSCC).
Experimental design: The mRNA expression levels of AURKA were compared in tumor tissues of 66 HNSCC patients with those in corresponding normal squamous epithelium by real-time quantitative reverse transcriptase-PCR. In addition, the association between AURKA mRNA and protein expression, centrosome abnormalities, and aneuploidy was studied in a subset of cases (n=34). All molecular variables were correlated to histomorphologic findings and clinical follow-up data of the patients.
Results: AURKA mRNA up-regulation was significantly associated with tumor stage and the occurrence of regional lymph node, as well as distant metastasis (P<0.0001 for all). Similarly, a correlation was found for protein expression and the occurrence of regional lymph node (P=0.0183) and distant metastasis (P=0.03). The mRNA was positively associated with protein expression (P=0.003) and centrosome abnormalities (P=0.03). Cox regression analysis revealed that AURKA mRNA up-regulation correlated with disease-free survival of the patients (P=0.03) as well as shorter overall survival (P<0.001).
Conclusions: We conclude that the up-regulation of AURKA mRNA may play a critical role in the tumor progression of HNSCC and provides useful information as a prognostic factor for HNSCC patients.
Comment in
-
Aurora sheds light on head and neck squamous cell carcinoma.Clin Cancer Res. 2006 Sep 1;12(17):5003-4. doi: 10.1158/1078-0432.CCR-06-1329. Clin Cancer Res. 2006. PMID: 16951211 Review. No abstract available.
-
Prognostic biomarkers in head and neck cancer.Clin Cancer Res. 2006 Sep 1;12(17):5005-6. doi: 10.1158/1078-0432.CCR-06-1356. Clin Cancer Res. 2006. PMID: 16951212 Review. No abstract available.
Similar articles
-
Prognostic biomarkers in head and neck cancer.Clin Cancer Res. 2006 Sep 1;12(17):5005-6. doi: 10.1158/1078-0432.CCR-06-1356. Clin Cancer Res. 2006. PMID: 16951212 Review. No abstract available.
-
Aurora sheds light on head and neck squamous cell carcinoma.Clin Cancer Res. 2006 Sep 1;12(17):5003-4. doi: 10.1158/1078-0432.CCR-06-1329. Clin Cancer Res. 2006. PMID: 16951211 Review. No abstract available.
-
The clinical significance of Aurora-A/STK15/BTAK expression in human esophageal squamous cell carcinoma.Clin Cancer Res. 2005 Mar 1;11(5):1827-34. doi: 10.1158/1078-0432.CCR-04-1627. Clin Cancer Res. 2005. PMID: 15756006
-
Clinical significance of micrometastatic cells detected by E48 (Ly-6D) reverse transcription-polymerase chain reaction in bone marrow of head and neck cancer patients.Clin Cancer Res. 2004 Dec 1;10(23):7827-33. doi: 10.1158/1078-0432.CCR-04-1090. Clin Cancer Res. 2004. PMID: 15585614
-
A simple specific pattern of chromosomal aberrations at early stages of head and neck squamous cell carcinomas: PIK3CA but not p63 gene as a likely target of 3q26-qter gains.Cancer Res. 2001 May 15;61(10):4122-9. Cancer Res. 2001. PMID: 11358835
Cited by
-
Aurora-A modulates MMP-2 expression via AKT/NF-κB pathway in esophageal squamous cell carcinoma cells.Acta Biochim Biophys Sin (Shanghai). 2016 Jun;48(6):520-7. doi: 10.1093/abbs/gmw030. Epub 2016 Apr 28. Acta Biochim Biophys Sin (Shanghai). 2016. PMID: 27125974 Free PMC article.
-
AURKA Phe31Ile polymorphism interacted with use of alcohol, betel quid, and cigarettes at multiplicative risk of oral cancer occurrence.Clin Oral Investig. 2015 Nov;19(8):1825-32. doi: 10.1007/s00784-015-1432-5. Epub 2015 Feb 21. Clin Oral Investig. 2015. PMID: 25697104 Clinical Trial.
-
A Novel Nine-Gene Signature Associated With Immune Infiltration for Predicting Prognosis in Hepatocellular Carcinoma.Front Genet. 2021 Nov 30;12:730732. doi: 10.3389/fgene.2021.730732. eCollection 2021. Front Genet. 2021. PMID: 34917126 Free PMC article.
-
Effects of stable knockdown of Aurora kinase A on proliferation, migration, chromosomal instability, and expression of focal adhesion kinase and matrix metalloproteinase-2 in HEp-2 cells.Mol Cell Biochem. 2011 Nov;357(1-2):95-106. doi: 10.1007/s11010-011-0879-1. Epub 2011 May 18. Mol Cell Biochem. 2011. PMID: 21590355
-
Melanoma: oncogenic drivers and the immune system.Ann Transl Med. 2015 Oct;3(18):265. doi: 10.3978/j.issn.2305-5839.2015.08.06. Ann Transl Med. 2015. PMID: 26605311 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous